tetradecanoylphorbol acetate has been researched along with Atrial Fibrillation in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boutjdir, M; Chahine, M; Mancarella, S; Qu, Y | 1 |
1 other study(ies) available for tetradecanoylphorbol acetate and Atrial Fibrillation
Article | Year |
---|---|
Protein kinase C activation inhibits alpha1D L-type Ca channel: a single-channel analysis.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Atrial Fibrillation; Barium; Calcium Channel Agonists; Calcium Channels, L-Type; Carcinogens; Cell Line; Enzyme Activation; Humans; Ion Channel Gating; Kidney; Kinetics; Patch-Clamp Techniques; Protein Kinase C; Rats; Tetradecanoylphorbol Acetate | 2008 |